DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 11, 2010, Pages 4985-4992

  Shufelt, Chrisandra ^a   Bretsky, Philip ^a   Almeida, Cristina M ^a   Johnson, B Delia ^b   Shaw, Leslee J ^c   Azziz, Ricardo ^a   Braunstein, Glenn D ^a   Pepine, Carl J ^d   Bittner, Vera ^e   Vido, Diane A ^f   Stanczyk, Frank Z ^g   Merz, C Noel Bairey ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f ALLEGHENY GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH ORGANIZATION; POSTMENOPAUSE; PRIORITY JOURNAL; STROKE;

EID: 78049520519     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0143     Document Type: Article

References (36)

1. Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B 1997 Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82:2396-2402
2. Tannenbaum C, Barrett-Connor E, Laughlin GA, Platt RW 2004 A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study. Eur J Endocrinol 151:717-725
3. Barrett-Connor E, Khaw KT, Yen SS 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519-1524
4. LaCroix AZ, Yano K, Reed DM 1992 Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men. Circulation 86:1529-1535
5. Trivedi DP, Khaw KT 2001 Dehydroepiandrosterone sulfate and mortality in elderly men and women. J Clin Endocrinol Metab 86:4171-4177
6. Golden SH, Maguire A, Ding J, Crouse JR, Cauley JA, Zacur H, Szklo M 2002 Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 155:437-445
7. Johannes CB, Stellato RK, Feldman HA, Longcope C, McKinlay JB 1999 Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study. J Clin Epidemiol 52:95-103
8. Barrett-Connor E, Goodman-Gruen D 1995 Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation 91:1757-1760
9. Thijs L, Fagard R, Forette F, Nawrot T, Staessen JA 2003 Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies. Acta Cardiol 58:403-410
10. Bernini GP, Moretti A, Sgró M, Argenio GF, Barlascini CO, Cristofani R, Salvetti A 2001 Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause 8:43-50
11. Herrington DM 1995 Dehydroepiandrosterone and coronary atherosclerosis. Ann NY Acad Sci 774:271-280
12. Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich Jr PO, Pearson TA 1990 Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 16:862-870
13. Bernini GP, Sgro' M, Moretti A, Argenio GF, Barlascini CO, Cristofani R, Salvetti A 1999 Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 84:2008-2012
14. Legrain S, Berr C, Frenoy N, Gourlet V, Debuire B, Baulieu EE 1995 Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology 41:343-351
15. Tilvis RS, Kahonen M, Harkonen M 1999 Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population. Aging (Milano) 11:30-34 (Pubitemid 29174098)
16. Cappola AR, Xue QL, Walston JD, Leng SX, Ferrucci L, Guralnik J, Fried LP 2006 DHEAS levels and mortality in disabled older women: the Women's Health and Aging Study I. J Gerontol A Biol Sci Med Sci 61:957-962
17. Johnson BD, Merz CN, Braunstein GD, Berga SL, Bittner V, Hodgson TK, Gierach GL, Reis SE, Vido DA, Sharaf BL, Smith KM, Sopko G, Kelsey SF 2004 Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) 13:872-887
18. Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, Sharaf BL, Sopko G 1999 The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 33:1453-1461
19. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ 2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93:1276-1284
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
21. Stanczyk FZ, Slater CC, Ramos DE, Azen C, Cherala G, Hakala C, Abraham G, Roy S 2009 Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women. Menopause 16:272-278
22. Orentreich N, Brind JL, Rizer RL, Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555
23. Reyna R, Traynor KD, Hines G, Boots LR, Azziz R 2001 Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormones. Fertil Steril 76:823-825
24. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, Sopko G, Kelsey SF, Holubkov R, Olson M, Miele NJ, Williams DO, Merz CN 2001 Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol 87:937-941; A3
25. Ostrowska Z, Zwirska-Korczala K, Pardela M, Drozdz M, Kos-Kudla B, Buntner B 1998 Circadian variations of androstenedione, dehydroepiandrosterone sulfate and free testosterone in obese women with menstrual disturbances. Endocr Regul 32:169-176
26. Azziz R, Bradley Jr E, Huth J, Boots LR, Parker Jr CR, Zacur HA 1990 Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time. J Clin Endocrinol Metab 70:1273-1279 (Pubitemid 120020164)
27. Ghadir S, Azziz R 2006 Reproducibility of the adrenal androgen response to adrenocorticotropic hormone stimulation. Fertil Steril 86:484-486
28. Thomas G, Frenoy N, Legrain S, Sebag-Lanoe R, Baulieu EE, Debuire B 1994 Serum dehydroepiandrosterone sulfate levels as an individual marker. J Clin Endocrinol Metab 79:1273-1276
29. Yildiz BO, Woods KS, Stanczyk F, Bartolucci A, Azziz R 2004 Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:5558-5562 (Pubitemid 39518440)
30. Cappola AR, O'Meara ES, Guo W, Bartz TM, Fried LP, Newman AB 2009 Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 64:1268-1274
31. Lapidus L, Lindstedt G, Lundberg PA, Bengtsson C, Gredmark T 1986 Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin Chem 32:146-152
32. Azziz R, Zacur HA, Parker Jr CR, Bradley Jr EL, Boots LR 1991 Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women. Fertil Steril 56:427-433
33. Ukkola O, Gagnon J, Rankinen T, Thompson PA, Hong Y, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C 2001 Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study. Eur J Endocrinol 145:1-9
34. Iwasaki Y, Asai M, Yoshida M, Nigawara T, Kambayashi M, Nakashima N 2004 Dehydroepiandrosterone-sulfate inhibits nuclear factor-κB-dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab 89:3449-3454
35. Nafziger AN, Bowlin SJ, Jenkins PL, Pearson TA 1998 Longitudinal changes in dehydroepiandrosterone concentrations in men and women. J Lab Clin Med 131:316-323
36. Kumar A, Woods KS, Bartolucci AA, Azziz R 2005 Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 62:644-649 (Pubitemid 40825931)